XORTX Therapeutics Inc. (TSXV:XRTX)
Canada · Delayed Price · Currency is CAD 0.6400
+0.1300 (25.49%)
At close: Mar 18, 2026
XORTX Therapeutics Market Cap
XORTX Therapeutics has a market cap or net worth of CAD 4.46 million as of March 20, 2026. Its market cap has decreased by -28.75% in one year.
Market Cap
4.46M
Enterprise Value
3.32M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.64
Market Cap Chart
Since January 11, 2018, XORTX Therapeutics's market cap has decreased from 31.46M to 4.46M, a decrease of -85.84%. That is a compound annual growth rate of -21.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 4.46M | -16.88% |
| Dec 30, 2025 | 5.36M | -8.88% |
| Dec 30, 2024 | 5.88M | 1.50% |
| Dec 29, 2023 | 5.80M | -64.03% |
| Dec 30, 2022 | 16.12M | -50.37% |
| Dec 31, 2021 | 32.47M | 175.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaTher Holdings | 6.37M |
| Restart Life Sciences | 5.93M |
| Aptose Biosciences | 5.69M |
| Kane Biotech | 5.46M |
| MYND Life Sciences | 5.22M |
| Quest PharmaTech | 5.07M |
| Cytophage Technologies | 4.40M |
| MindBio Therapeutics | 4.31M |